• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉注射利多卡因:老药新用——减轻化疗引起的周围神经病变患者的顽固性疼痛

Intravenous Lidocaine: Old-School Drug, New Purpose-Reduction of Intractable Pain in Patients with Chemotherapy Induced Peripheral Neuropathy.

作者信息

van den Heuvel Sandra A S, van der Wal Selina E I, Smedes Lotte A, Radema Sandra A, van Alfen Nens, Vissers Kris C P, Steegers Monique A H

机构信息

Department of Anesthesiology, Pain and Palliative Medicine, Radboud University Nijmegen Medical Center (RUNMC), Nijmegen, Netherlands.

Department of Medical Oncology, RUNMC, Nijmegen, Netherlands.

出版信息

Pain Res Manag. 2017;2017:8053474. doi: 10.1155/2017/8053474. Epub 2017 Mar 28.

DOI:10.1155/2017/8053474
PMID:28458593
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5387833/
Abstract

Treatment of intractable pain due to chemotherapy induced peripheral neuropathy (CIPN) is a challenge. Intravenous (iv) lidocaine has shown to be a treatment option for neuropathic pain of different etiologies. Lidocaine (1.5 mg/kg in 10 minutes followed by 1.5 mg/kg/h over 5 hours) was administered in nine patients with CIPN, and analgesic effect was evaluated during infusion and after discharge. The immediate effect of lidocaine on pressure pain thresholds (PPT) and the extent of the stocking and glove distribution of sensory abnormalities (cold and pinprick) were assessed. Lidocaine had a significant direct analgesic effect in 8 out of 9 patients ( = 0.01) with a pain intensity difference of >30%. Pain reduction persisted in 5 patients for an average of 23 days. Lidocaine did not influence mean PPT, but there was a tendency that the extent of sensory abnormalities decreased after lidocaine. Iv lidocaine has direct analgesic effect in CIPN with a moderate long-term effect and seems to influence the area of cold and pinprick perception. Additional research is needed, using a control group and larger sample sizes to confirm these results.

摘要

化疗引起的周围神经病变(CIPN)所致顽固性疼痛的治疗颇具挑战。静脉注射利多卡因已被证明是治疗不同病因所致神经病理性疼痛的一种选择。对9例CIPN患者静脉注射利多卡因(10分钟内注射1.5mg/kg,随后5小时内以1.5mg/kg/小时的速度注射),并在输液期间和出院后评估镇痛效果。评估了利多卡因对压力疼痛阈值(PPT)的即时影响以及感觉异常(冷觉和针刺觉)的袜套样和手套样分布范围。9例患者中有8例(P = 0.01)利多卡因具有显著的直接镇痛作用,疼痛强度差异>30%。5例患者的疼痛减轻持续平均23天。利多卡因对平均PPT无影响,但利多卡因注射后感觉异常范围有减小的趋势。静脉注射利多卡因对CIPN有直接镇痛作用,具有中度长期效果,似乎会影响冷觉和针刺觉的区域。需要使用对照组和更大样本量进行进一步研究以证实这些结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e843/5387833/b3b8c235d1f8/PRM2017-8053474.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e843/5387833/b21950fc8c50/PRM2017-8053474.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e843/5387833/b3b8c235d1f8/PRM2017-8053474.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e843/5387833/b21950fc8c50/PRM2017-8053474.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e843/5387833/b3b8c235d1f8/PRM2017-8053474.002.jpg

相似文献

1
Intravenous Lidocaine: Old-School Drug, New Purpose-Reduction of Intractable Pain in Patients with Chemotherapy Induced Peripheral Neuropathy.静脉注射利多卡因:老药新用——减轻化疗引起的周围神经病变患者的顽固性疼痛
Pain Res Manag. 2017;2017:8053474. doi: 10.1155/2017/8053474. Epub 2017 Mar 28.
2
Intravenous lidocaine in the management of chronic peripheral neuropathic pain: a randomized-controlled trial.静脉注射利多卡因治疗慢性周围神经性疼痛:一项随机对照试验。
Can J Anaesth. 2019 Jul;66(7):820-827. doi: 10.1007/s12630-019-01395-8. Epub 2019 May 16.
3
Intravenous Lidocaine Administered as Twice Daily Bolus and Continuous Infusion for Intractable Cancer Pain and Wound Care Pain.静脉注射利多卡因,每日两次推注和持续输注,用于治疗难治性癌痛和伤口护理疼痛。
J Palliat Med. 2019 Mar;22(3):343-347. doi: 10.1089/jpm.2018.0243. Epub 2018 Dec 1.
4
How to initiate and monitor infusional lidocaine for severe and/or neuropathic pain.如何启动和监测用于重度和/或神经性疼痛的静脉输注利多卡因。
J Support Oncol. 2004 Jan-Feb;2(1):90-4.
5
Intravenous Lidocaine Infusion to Treat Chemotherapy-Induced Peripheral Neuropathy.静脉输注利多卡因治疗化疗引起的周围神经病变。
A A Case Rep. 2015 Nov 1;5(9):154-5. doi: 10.1213/XAA.0000000000000197.
6
The efficacy of the AMPA receptor antagonist NS1209 and lidocaine in nerve injury pain: a randomized, double-blind, placebo-controlled, three-way crossover study.AMPA受体拮抗剂NS1209与利多卡因治疗神经损伤性疼痛的疗效:一项随机、双盲、安慰剂对照、三交叉研究。
Anesth Analg. 2009 Apr;108(4):1311-9. doi: 10.1213/ane.0b013e318198317b.
7
[The efficacy of intravenous lidocaine for acute herpetic pain--placebo controlled trial].[静脉注射利多卡因治疗急性疱疹性疼痛的疗效——安慰剂对照试验]
Masui. 2009 Nov;58(11):1413-7.
8
The analgesic effect of a metered-dose 8% lidocaine pump spray in posttraumatic peripheral neuropathy: a pilot study.定量8%利多卡因泵喷雾用于创伤后周围神经病变的镇痛效果:一项初步研究。
Anesth Analg. 2009 Mar;108(3):987-91. doi: 10.1213/ane.0b013e31819431aa.
9
Intravenous Lidocaine for Refractory Pain in Patients With Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis: A Multicenter Prospective Nonrandomized Pilot Study.静脉注射利多卡因治疗胰腺导管腺癌和慢性胰腺炎患者的难治性疼痛:一项多中心前瞻性非随机试点研究。
Clin Transl Gastroenterol. 2024 Sep 1;15(9):e1. doi: 10.14309/ctg.0000000000000760.
10
A randomized, double-masked, placebo-controlled pilot trial of extended IV lidocaine infusion for relief of ongoing neuropathic pain.一项关于延长静脉输注利多卡因以缓解持续性神经性疼痛的随机、双盲、安慰剂对照试验。
Clin J Pain. 2006 Mar-Apr;22(3):266-71. doi: 10.1097/01.ajp.0000169673.57062.40.

引用本文的文献

1
Mechanisms and Management of Albumin-Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer.白蛋白结合型紫杉醇诱导的乳腺癌周围神经病变的机制与管理
Breast Cancer (Dove Med Press). 2025 Aug 13;17:693-709. doi: 10.2147/BCTT.S531877. eCollection 2025.
2
Multiday intravenous ketamine infusion therapy for the management of central sensitisation syndrome secondary to chronic chemotherapy-induced peripheral neuropathic pain.多日静脉输注氯胺酮疗法用于治疗慢性化疗诱导的周围神经性疼痛继发的中枢敏化综合征。
BMJ Case Rep. 2025 Jul 3;18(7):e265205. doi: 10.1136/bcr-2025-265205.
3
Lidocaine Enhanced Antitumor Efficacy and Relieved Chemotherapy-Induced Hyperalgesia in Mice with Metastatic Gastric Cancer.

本文引用的文献

1
The in vitro mechanisms and in vivo efficacy of intravenous lidocaine on the neuroinflammatory response in acute and chronic pain.静脉注射利多卡因对急慢性疼痛神经炎症反应的体外机制及体内疗效
Eur J Pain. 2016 May;20(5):655-74. doi: 10.1002/ejp.794. Epub 2015 Dec 18.
2
Chemotherapy-induced peripheral neurotoxicity in cancer survivors: an underdiagnosed clinical entity?癌症幸存者中化疗引起的周围神经毒性:一种诊断不足的临床病症?
Am Soc Clin Oncol Educ Book. 2015:e553-60. doi: 10.14694/EdBook_AM.2015.35.e553.
3
Individualized pharmacological treatment of neuropathic pain.
利多卡因增强转移性胃癌小鼠的抗肿瘤疗效并减轻化疗诱导的痛觉过敏。
Int J Mol Sci. 2025 Jan 19;26(2):828. doi: 10.3390/ijms26020828.
4
Chemotherapy-Induced Peripheral Neuropathy: A Recent Update on Pathophysiology and Treatment.化疗引起的周围神经病变:病理生理学与治疗的最新进展
Life (Basel). 2024 Aug 9;14(8):991. doi: 10.3390/life14080991.
5
The Pharmacological Treatment of Neuropathic Pain in Children.儿童神经病理性疼痛的药物治疗。
Curr Neuropharmacol. 2024;22(1):38-52. doi: 10.2174/1570159X21666230804110858.
6
Ozone in Chemotherapy-Induced Peripheral Neuropathy-Current State of Art, Possibilities, and Perspectives.臭氧疗法治疗化疗诱导性周围神经病:现状、可能性与展望。
Int J Mol Sci. 2023 Mar 9;24(6):5279. doi: 10.3390/ijms24065279.
7
Serum sodium ions and chloride ions associated with taxane-induced peripheral neuropathy in Chinese patients with early-stage breast cancer: A nation-wide multicenter study.血清钠离子和氯离子与中国早期乳腺癌患者紫杉烷类诱导的周围神经病变相关:一项全国多中心研究。
Breast. 2023 Feb;67:36-45. doi: 10.1016/j.breast.2022.12.034. Epub 2022 Dec 28.
8
Emerging Approaches for the Management of Chemotherapy-Induced Peripheral Neuropathy (CIPN): Therapeutic Potential of the C5a/C5aR Axis.化疗诱导的周围神经病变(CIPN)管理的新兴方法:C5a/C5aR轴的治疗潜力
Pain Ther. 2022 Dec;11(4):1113-1136. doi: 10.1007/s40122-022-00431-8. Epub 2022 Sep 13.
9
Treatment and diagnosis of chemotherapy-induced peripheral neuropathy: An update.化疗引起的周围神经病的治疗和诊断:最新进展。
Biomed Pharmacother. 2022 Mar;147:112671. doi: 10.1016/j.biopha.2022.112671. Epub 2022 Jan 29.
10
Role of Intravenous Lidocaine Infusion in the Treatment of Peripheral Neuropathy.静脉输注利多卡因在周围神经病变治疗中的作用
Orthop Rev (Pavia). 2021 Jul 11;13(2):25567. doi: 10.52965/001c.25567. eCollection 2021.
个体化药物治疗神经病理性疼痛。
Clin Pharmacol Ther. 2015 Feb;97(2):135-42. doi: 10.1002/cpt.19. Epub 2014 Dec 15.
4
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis.成人神经性疼痛的药物治疗:一项系统评价与荟萃分析。
Lancet Neurol. 2015 Feb;14(2):162-73. doi: 10.1016/S1474-4422(14)70251-0. Epub 2015 Jan 7.
5
Systematic mechanism-orientated approach to chronic pancreatitis pain.针对慢性胰腺炎疼痛的系统性机制导向方法。
World J Gastroenterol. 2015 Jan 7;21(1):47-59. doi: 10.3748/wjg.v21.i1.47.
6
Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms?化疗引起的周围神经病:我们对发病机制了解多少?
Neurosci Lett. 2015 Jun 2;596:90-107. doi: 10.1016/j.neulet.2014.10.014. Epub 2014 Oct 22.
7
Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis.化疗引起的周围神经病变的发病率、患病率及预测因素:一项系统评价和荟萃分析。
Pain. 2014 Dec;155(12):2461-2470. doi: 10.1016/j.pain.2014.09.020. Epub 2014 Sep 23.
8
Chemotherapy-induced neuropathy: A comprehensive survey.化疗诱导性神经病:全面调查。
Cancer Treat Rev. 2014 Aug;40(7):872-82. doi: 10.1016/j.ctrv.2014.04.004. Epub 2014 Apr 18.
9
Characterization and diagnostic evaluation of chronic polyneuropathies induced by oxaliplatin and docetaxel comparing skin biopsy to quantitative sensory testing and nerve conduction studies.奥沙利铂和多西他赛诱导的慢性多发性神经病的特征和诊断评估:皮肤活检与定量感觉测试和神经传导研究比较。
Eur J Neurol. 2014 Apr;21(4):623-9. doi: 10.1111/ene.12353. Epub 2014 Jan 25.
10
Quantitative sensory testing predicts pregabalin efficacy in painful chronic pancreatitis.定量感觉测试可预测普瑞巴林治疗慢性胰腺炎疼痛的疗效。
PLoS One. 2013;8(3):e57963. doi: 10.1371/journal.pone.0057963. Epub 2013 Mar 1.